Skip to content

Use of warm Intravenous Fluid for Prevention of shivering and fall internal in body temperature in orthopedic surgical patients.

Use of Prewarmed Intravenous Fluid for Prevention of Perioperative Hypothermia and Shivering in patients undergoing lower limb arthroplasty surgeries - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100478
Enrollment
80
Registered
2026-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee Health Condition 2: M19- Other and unspecified osteoarthritis

Interventions

Intervention1: Prewarmed intravenous fluid at 40 Degree given in intervention and fluid at 20 degree Celsius to comparator group.: Group one will be given intravenous fluid at room temperature(20 Degr

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All gender consenting patients undergoing hip or knee arthroplasty surgeries

Exclusion criteria

Exclusion criteria: Patients who will have baseline core body temperature more than 38 or less than 36 Degree Celsius. Patients with impacted wax, perforation of the tympanic membrane, middle/ external ear infections. Those with urinary tract infections, diabetic autonomic neuropathy or any neurological diseases. Patients with deranged coagulation profile. Those with history of allergy to the local anesthetic

Design outcomes

Primary

MeasureTime frame
Effect of prewarmed intravenous fluid and intravenous fluid at room temperature on core body temperature(tympanic membrane temperature measured by ear thermometer) and shivering, when given to patient during the arthroplasty surgical procedure.Timepoint: Primary outcomes will be assessed at start of surgery, at everyone minute for first 5 minutes, at every 30 mins till completion of surgery(2.5-3.5 hours) in both the groups. In recovery room we will assess the outcome at 0min(when patient reach in recovery room),30min,60min 90min and 120min.

Secondary

MeasureTime frame
To determine the effect of prewarmed intravenous fluid on patient s hemodynamic profile, VAS Score, incidence of nausea vomiting & time to discharge the patient from recovery room. To identify any specific untoward side effects/ complications due to infusion of prewarmed intravenous fluid.Timepoint: Secondary outcomes will be assessed at start of surgery, at everyone minute for first 5 minutes, at every 30 mins till completion of surgery(2.5-3.5 hours) in both the groups. In recovery room we will assess the outcome at 0min(when patient reach in recovery room),30min,60min 90min & 120min.

Countries

India

Contacts

Public ContactDr Mridul Madhav Panditrao

Adesh University, Bathinda

sonaattri45@gmail.com09915461044

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026